Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - NEVINNY CORINNE H
Last Updated 
31-Mar-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

NEVINNY CORINNE H: Declared Holdings
Company/RelationshipReportedShares  Ownership
Avanir Pharmaceuticals, Inc.
Director
NasdaqGS:AVNR
(historical quotes, profile, other insiders)
12-Feb-1480,050  Direct
Neurocrine Biosciences, Inc.
Director
NasdaqGS:NBIX
(historical quotes, profile, SEC, other insiders)
28-Mar-131,531  Direct
ONYX Pharmaceuticals, Inc.
Director
NasdaqGS:ONXX
(historical quotes, SEC, other insiders)
1-Oct-130  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
12-Feb-14 21,700AVNR Acquisition (Non Open Market)
1-Oct-13 2,100ONXX Disposition (Non Open Market) at $125 per share.
(Value of $262,500)
30-Jul-13 1,500ONXX Automatic Sale at $131.26 per share.
(Proceeds of $196,890)
1-Jul-13 5,000ONXX Automatic Sale at $132.63 per share.
(Proceeds of $663,150)
19-Jun-13 1,000ONXX Automatic Sale at $88.25 per share.
(Proceeds of $88,250)
28-Mar-13 2,100ONXX Acquisition (Non Open Market) at $0 per share.
28-Mar-13 12,000NBIX Option Exercise at $10.60 per share.
(Cost of $127,200)
28-Mar-13 10,469NBIX Disposition (Non Open Market) at $12.15 per share.
(Value of $127,198)
11-Mar-13 58,350AVNR Acquisition (Non Open Market)
28-Nov-12 3,964ONXX Sale at $75 per share.
(Proceeds of $297,300)
25-Jul-12 1,500ONXX Acquisition (Non Open Market) at $0 per share.


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?